ArticleHuman molecular genetics2020

Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins.

Kayalvizhi Madhivanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.